Toronto company Cannalogue became a lightning rod for anger when it submitted an application to Health Canada to study the effects of cannabis on COVID-19, a move that appeared to some an attempt to profit from a crisis there’s no suggestion cannabis can help. (The International Association of Cannabinoid Medicines issued a statement underlining the lack of evidence “that individual cannabinoids […] or cannabis preparations protect against infection with the SARS-CoV2 or could be used to treat COVID-19.”)
Twitter–RebeccaSaah, @ErinProsk, @IACM_Bulletin
PSA: Any company or individual can submit to study cannabis as a treatment for anything. Significant documentation must be submitted justifying safety & validity of the drug and of the study, also approval by independent ethics board. Approval would be news but 'submission' isn't https://t.co/VPbL9XKHHK
— Erin Prosk (@ErinProsk) March 27, 2020
The distinction between an submission and approval didn’t stop multiple news sources from reporting on the story without interviewing anyone critical of the move.
GrowthOp, Toronto Sun, Cannabis Retailer
Quick Hits
- After years of demands from advocates, the COVID crisis has forced the city of Vancouver—with permission from the federal government—to introduce a safe supply of opioids, stimulants, and benzodiazepines for drug consumers on the Downtown East Side.
Twitter–@angelasterritt, CBC Vancouver
